A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumor and Other Solid Tumor — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(6 sites)
China
Beijing Cancer Hospital, Beijing, Beijing Municipality The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Jinan Central Hospital, Jinan, Shandong West China Hospital, Sichuan University, Chengdu, Sichuan Tianjin Medical University General Hospital, Tianjin, Tianjin Municipality Zhejiang Cancer Hospital, Hangzhou, Zhejiang Age range
18 Years – 75 Years
Last updated September 2025